| 发明名称 |
Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors |
| 摘要 |
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
|
| 申请公布号 |
US2011020276(A1) |
申请公布日期 |
2011.01.27 |
| 申请号 |
US20090922752 |
申请日期 |
2009.03.25 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
YANG ZHONG;BENDER JOHN A.;KADOW JOHN F. |
| 分类号 |
A61K38/20;A61K31/55;A61K38/16;A61K38/21;A61P31/12;C07D487/14 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
